A POPULATION of cryopreserved human AML cells was available in our laboratory which grew proliferatively for 2 weeks in liquid culture. The detailed histochemical enzymatic and surface characteristics of these cells and their progressive changes in culture are the subject of a comprehensive report (Palu et al., 1979) . We showed that dividing cells in culture, regardless of phenotype, carried a characteristic abnormality of Chromosome Number 11. The purpose of this investigation was to examine whether it was possible to produce transplantable xenografts from this cell population and to compare in vivo tumorigenicity with the gradual maturation towards macrophages which occurs in vitro. In earlier investigations, Franks et al. (1977) had reported that AML cells taken directly from patients gave rise to small tumours in immune-deprived mice, but that these regressed. A further objective of this study was, therefore, to determine * To whom correspondence should be addressed.
whether progressively growing xenografts could be obtained from AML cells grown for short periods in vitro and not having the properties of established tissue-culture cell lines.
MATERIALS AND METHODS
AML cells-.One population of AML cells was studied. They were removed using a Blood Cell Separator (Powles et al., 1974) from an untreated 17-year-old female with AML, whose WBC count was 96-6 x 109/1. They were then stored in liquid N2 and karyotyped as described in Chapuis et al. (1977) and Palu' et al. (1979) . Culture conditions were as described in those papers.
Technique for proliferative cultures of AML cells-.Cultures were established in 35mm Petri dishes as described by Palu' et al (1979) . The cells growing in suspension were counted with a standard haemacytometer. Cells adherent to the plate were enumerated in situ with a calibrated objective, or alternatively after the nuclei had been detached from the cytoplasm with 0 1M citric acid. Xenografts.-Male CBA mice were used, which had been rendered immuno-deprived by neonatal thymectomy, followed after 2-4 weeks by a priming dose of Ara-C 200 mg/kg and 900R total body irradiation as described (Steel et al., 1978; Millar et al., 1978) . The animals were prepared by Mr E. M. Merryweather of the Division of Biophysics animal department. AML cells were injected s.c. in the dorsal anterior region of the animals, after having been cultured for 1, 7, 13 days and on occasion separated into Fc+ and Fcpopulations by adherence. Tumour growth was measured with a caliper, recording 2 diameters at right angles of the s.c. nodules.
Cellular composition of xenograft tumours. After removal of growths of between 0-3 and 0-7 cm diameter, they were cut into small fragments and a cell suspension made by dissociation in 0-1% trypsin, 0.1% collagenase and 0.01% DNAse. The cells so obtained were tested for Fc receptors immediately after enzymatic dispersion and after 24h culture. The percentage of mouse cells present within these tumours was assayed using a CBA anti-human serum in complementdependent lysis. The antiserum was obtained after multiple immunization of normal male CBA with the same AML population used for tumour induction in the immune-deprived CBA. Lyophilized rabbit serum served as the source of complement, after adsorption with AML cells. Cytochemical studies were as described by Palui et al. (1979) .
RESULTS

In vitro maturation and proliferation
The figure shows that the AML cells recovered from cryopreservation proliferate in liquid culture and increase in number about 7-fold over a period of 2 weeks. The culture consists of 2 types of cells, those that remain in suspension and those Franks, 1977 ) that after inoculation of 107 cells 40% of the assessable tumour nodules grew progressively, although half of these showed an initial regression (see Table II ). Progressively growing tumours could be further transplanted. Morphologically these tumours were human AML cells, with many mitotic figures showing the characteristic chromosome marker of this population. The nodules were dispersed enzymatically, and more than 95% of the resulting cells were lysed by a mouse anti-human serum in the presence of complement. Table I , synthesized DNA. After separation by in vitro adherence into 2 populations which were respectively > 900o Fc+ and < 10% Fc+, only the Fccells grew as xenografts. In each of the 6 instances, the tumours derived from the cells that had been cultured for 7 days regressed even though the inoculum consisted of 107 cells.
After 13 days of culture the nonadherent cells which were viable (i.e. excluded trypan blue) and looked morphologically normal failed to grow as xenografts in 10 animals tested. More than 9000 of these cells were Fc+ and 7000 were positive for nonspecific esterase activity. However, these Fc+ cells did not appear to inhibit the growth in vivo of the Fe-cells, since in one experiment involving 3 animals, 107 Fe-(Day 1 culture) cells when inoculated admixed with 5 x 106 Fc+ (Day 13) cells grew as xenografts (see Table II) . Table III provides some evidence that the regression of xenografts is accompanied by maturation. Cells derived from tumours which had passed their maximum size of -7 mm in diameter, and at excision were in the range of 4 cm in diameter, had a greatly increased incidence of Fc+ and nonspecific-esterase-positive cells than the original inoculum. Maturation was much less evident in the 2 progressively growing tumours studied. DISCUSSION Franks et al. (1977) (Table I) .
A remarkable aspect of the growth as xenografts of the AML cells, either when taken directly from the patient or from short-term culture, is the high incidence of spontaneous regression of the nodules after 2-3 weeks. The regression of these Fe-AML cells is unlikely to be caused by an immune rejection, since if this were the case we would anticipate an inverse relationship between the size of the cell inoculum and the incidence of regression, but this is not found (see Table II ). But, 
